Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.28 USD | -0.07% | -0.41% | +8.10% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
Financials (USD)
Sales 2024 * | 447M | Sales 2025 * | 537M | Capitalization | 3.44B |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | 36M | EV / Sales 2024 * | 6.95 x |
Net cash position 2024 * | 329M | Net cash position 2025 * | 370M | EV / Sales 2025 * | 5.71 x |
P/E ratio 2024 * |
-696
x | P/E ratio 2025 * |
96
x | Employees | 797 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Axonics, Inc.
1 day | -0.44% | ||
1 week | -0.50% | ||
Current month | +1.14% | ||
1 month | +1.29% | ||
3 months | -1.55% | ||
6 months | +16.43% | ||
Current year | +8.20% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 12-12-31 | |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Kari Keese
DFI | Director of Finance/CFO | 39 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Carrel
CHM | Chairman | 53 | 19-02-26 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 19-04-07 |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 11 M€ | -6.03% | - | |
0.09% | 430 M€ | -.--% | ||
0.05% | 746 M€ | -.--% | - | |
0.04% | 234 M€ | +7.37% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 67.27 | -0.09% | 44 283 |
24-05-23 | 67.33 | -0.44% | 559,373 |
24-05-22 | 67.63 | +0.06% | 505,077 |
24-05-21 | 67.59 | +0.07% | 253,786 |
24-05-20 | 67.54 | -0.01% | 163,774 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.20% | 3.44B | |
+10.24% | 126B | |
-9.51% | 10.89B | |
+3.31% | 9.02B | |
+35.16% | 5.41B | |
-23.90% | 4.6B | |
-10.69% | 2.74B | |
-12.15% | 2.06B | |
-11.96% | 1.96B | |
-27.62% | 1.68B |
- Stock Market
- Equities
- AXNX Stock